The Role of mTOR Inhibitors after Liver Transplantation for Hepatocellular Carcinoma

Liver transplantation is a treatment option for nonresectable patients with early-stage HCC, with more significant advantages when Milan criteria are fulfilled. An immunosuppressive regimen is required to reduce the risk of graft rejection after transplantation, and CNIs represent the drugs of choic...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Letizia Todeschini, Luca Cristin, Alessandro Martinino, Amelia Mattia, Salvatore Agnes, Francesco Giovinazzo
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2023-06-01
Colecção:	Current Oncology
Assuntos:	hepatocellular carcinoma HCC immunosuppression liver transplantation mTOR mTOR inhibitors
Acesso em linha:	https://www.mdpi.com/1718-7729/30/6/421
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!